Purpose-Several chronic pain conditions may be distinguished by condition-specific brain anatomical and functional abnormalities observed by imaging suggestive of underlying disease processes. Here we present the first characterization of IC/BPS-associated white matter (axonal) abnormalities based on multi-center neuroimaging from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
INTRODUCTION
Interstitial cystitis/bladder pain syndrome (IC/BPS) is characterized by symptoms of persistent pelvic pain, urinary frequency, and urgency that are notoriously difficult to treat 1, 2 . IC/BPS exacts a heavy toll on mood, sexual function, daily functioning, and quality of life [3] [4] [5] . IC/BPS continues to exact a heavy toll on mood, sexual function, daily functioning, and quality of life, despite numerous treatments directed towards peripheral pathology (e.g. inflammatory, infectious, muscular, and afferent abnormalities) 6 . Advances in the clinical conceptualization, diagnosis, and treatment of IC/BPS have been hampered by a paucity of biomarker evidence for peripheral and central mechanisms responsible for the initiation and maintenance of this syndrome.
Pain neuroimaging studies have demonstrated that clinical pain conditions exhibit unique changes in brain anatomy and function 7 . In healthy and disease states, brain anatomy and function are closely linked because neuronal activity is constrained by the structure and arrangement of neurons and axons that relay information 8 . White (axonal) matter facilitates the communication of neural information between and within brain regions, and abnormalities in these tracts can conceivably disrupt processing of sensory, motor, cognitive, and emotional information. Axonal structural integrity is inferred from the directions of water flow along the length of myelinated axons and is measured as fractional anisotropy (FA). The identification of anisotropic abnormalities in chronic prostatitis/ chronic pelvic pain, irritable bowel syndrome, low back pain, and other pain conditions, strongly implies that axonal alterations play a mechanistic role in the development and/or maintenance of chronic pain [9] [10] [11] [12] .
We report the first characterization of brain white matter anomalies in women with IC/BPS using non-invasive brain imaging technology as part of the multi-center Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. Diffusion tensor imaging (DTI) was used to evaluate water diffusion properties along axonal tracts in women with IC/BPS compared to healthy women We hypothesized that a combination of regional increases and decreases in anisotropy in regions mediating sensorimotor, modulatory, and cognitive processing would characterize IC/BPS and correlate with clinical symptoms of IC/ BPS.
MATERIALS AND METHODS
A convenience sample of participants from the MAPP Epidemiology/Phenotyping (EP) Study received DTI (n=201), gray matter anatomical (n=301), and resting state functional scans (n=297) 1, 13 . Here we report DTI data of female IC/BPS and gender/age-matched controls enrolled at Northwestern University (NU), University of California at Los Angeles (UCLA), and Stanford University (SU) between January 2011 and November 2013. All procedures were approved by the Institutional Review Boards of the respective sites, and participants provided written informed consent.
Participants
Twenty-two women meeting criteria for IC/BPS were compared to age-matched (± 3 years) healthy control women (n=32) (fig 1) . Data from patients were excluded if they lacked agematched controls (including 18 women with IC/BPS and 2 controls). IC/BPS patients who fulfilled MAPP inclusion/exclusion criteria (suppl. table 1) reported pelvic pain, pressure, or discomfort during the majority of the previous 3 months, with >1/10 mean pelvic pain intensity (0 indicating no pain and 10 indicating worst imaginable pain).
Experimental Design
Patients underwent DTI and T1-weighted scans in a single visit. Questionnaires administered included the Symptom and Health Care Utilization Questionnaire (SYM-Q), Hospital Anxiety and Depression Scale (HADS), McGill Pain Questionnaire-Short Form (SF-MPQ), Gracely Box Scales, Positive and Negative Affective Scales (PANAS), and the Genitourinary Pain Index (GUPI), including pain, urinary function, and quality of life subdomains.
Imaging data acquisition
MRI scanning was performed at multiple sites using different scanner technology [3 Tesla (T) Siemens Trio (NU and UCLA), and 3T GE Discovery (SU)]. Neuroimaging data were collected, underwent quality control, and archived according to multi-site imaging procedures developed collaboratively between the MAPP Research Network, the UCLA PAIN repository and the UCLA Laboratory of Neuroimaging. Detailed procedures and description of the repository are available at PAINrepository.org and acquisition parameters are described in the Supplementary Methods. All centers completed and passed center qualifications, including a set of pilot scans of a human volunteer.
DATA ANALYSIS
DTI and T1-weighted images were obtained using the protocol described by Geha and colleagues 14 (see suppl. methods). Group contrasts of patient and control white matter yielded regions of interest (ROIs) that differed between groups (p < 0.001, corrected for multiple comparisons). Measures of white matter diffusivity (FA, axial diffusivity, radial diffusivity, and mean diffusivity) for each ROI were examined with planned post-hoc Student's t-tests or Mann-Whitney U Rank Sums tests for non-normally distributed data. Clinical parameters were correlated with ROI anisotropy using Pearson correlations (Bonferroni corrected for multiple comparisons, p < 0.005).
RESULTS

Participant Characteristics
The IC/BPS group (mean age=38.7) consisted of 95% Caucasian and 5% Hispanic patients reporting 11.4 years average pain duration and 4/10 average pain intensity (moderate clinical pain) on day of scanning. Total GUPI scores ranged from 1-38 (mean = 24.5, SE=2.2), with an average pain subscore of 11.4 (SE=1.05). GUPI-defined pain locations included the entrance to the vagina (41%), vagina (41%), urethra (59%), and below the waist in the pubic or bladder area (91%, refer to suppl. figure 1) . Eight patients were taking medications, including oral narcotics (n=3), amitriptyline (n=4), cyclosporine (n=1), antimuscarinics (n=1), lyrica /neurontin/or tegretol (n=2), NSAIDs (n=1), valium (n=1) and a SSRI (n=1). Clinical parameters are summarized in Table 1 (refer to suppl. table 2 for detailed clinical profiles).
Determination of center and age effects
Pooling imaging data from multiple centers can introduce variability due to technological differences and center recruitment biases. Indeed, mean FA values differed between centers (f 2,148 = 13.91, p < 0.001, fig 2B) . To adjust for center effect, each subject's voxel-wise FA was corrected with the center's mean FA, and this value was added to the multi-center Grand mean FA (see suppl. methods section). Center-corrected FA values were negatively correlated with age, in agreement with previous studies ( fig 2C) . All subsequent analyses reflect center-and age-adjusted values.
Whole brain contrast for white matter integrity differences
A whole-brain voxel-wise comparison using a common white matter skeleton was conducted to identify differences between IC/BPS and controls. Regional white matter reductions in patients (Control > Patient contrast) were observed in the (a) corticospinal tract in the left cerebellum, (b) anterior thalamic radiation in the right cerebellum, (c) right inferior fronto-occipital fasciculus in the right frontal orbital cortex, (d) right inferior longitudinal fasciculus in the lateral occipital cortex, (e) left forceps major adjacent to the precuneus, (f) right anterior thalamic radiation in the right frontal pole, (g) superior longitudinal fasciculus in the parietal cortex, and (h) temporal part of the left superior longitudinal fasciculus near the anterior cingulate cortex (ACC). In contrast, increased white matter FA in patients (Patient > Control contrast) was evident in the (a) inferior longitudinal fasciculus, (b) inferior fronto-occipital fasciculus bordering the right insula (INS), (c) forceps major near the left ACC, (d) superior longitudinal fasciculus in the right postcentral gyrus, as well as (e) left primary somatosensory cortex (S1), and (f) corticospinal tract passing through left S1. 
White matter properties of clinically-relevant regions
We hypothesized that abnormalities in white matter microstructure in IC/BPS would correlate with pain and urinary measures. FA (a general measure of white matter integrity) and diffusivity measures for specific directions were measured, including diffusion along the principle tract direction (axial diffusivity), diffusion perpendicular to the principle direction (radial diffusivity), and an average of diffusion in all directions (mean diffusivity). Additional planned post-hoc analyses were restricted to the originally identified ROIs (see above). Three areas of increased FA and three areas of decreased FA were correlated with syndrome-specific parameters (figs 3 and 4). Regional anisotropy in the left forceps major was significantly reduced in IC/BPS compared to controls (t 1,52 = 2.63, p =0.01, fig 3B) , with a concurrent increase in radial diffusivity (t 
DISCUSSION
Our findings reveal altered white matter microstructure across multiple axonal tracts in women with IC/BPS. Using diffusion-based neuroimaging, we identified both decreases and increases in regional white matter properties related to IC/BPS. Specifically, reduced anisotropy located in portions of the anterior thalamic radiation, forceps major, and inferior longitudinal fasciculus were associated with more severe pelvic pain, urinary symptoms, and poorer quality of life. Increased anisotropy in portions of the bilateral inferior longitudinal fasciculus and superior longitudinal fasciculus correlated with pain severity and urinary dysfunction. Collectively, these microstructural abnormalities may influence the flow of neural information throughout the brain, thereby mediating brain reorganization previously observed in male pelvic pain 10 . This hypothesis is supported by IC/BPS-related shifts in oscillatory patterns of neuronal activity (function) and increased grey matter density (structure) in regions that modulate visceral and somatosensation and potentially pelvic floor motor function in women with IC/BPS 15, 16 . These anatomical abnormalities are strongly suggestive of neuropathological processes underlying IC/BPS.
Structural changes in axonal pathways can conceivably alter brain function in a diseasespecific manner 17 . White matter abnormalities have been identified in multiple chronic pain conditions, including male pelvic pain, irritable bowel syndrome, low back pain, temporomandibular disorder, headache, fibromyalgia, and complex regional pain syndrome [9] [10] [11] [18] [19] [20] [21] . Each condition has exhibited different patterns of altered microstructure, or white matter "signatures," that may underlie distinct disease processes mediating the respective clinical symptoms. Despite these differences, IC/BPS also exhibits regional white matter abnormalities described in other pain conditions, including axonal projections to sensorimotor regions (e.g., thalamus, premotor area, S1), modulatory hubs serving diverse cognitive, emotional, and autonomic functions (e.g., ACC, INS), and frontal cortical regions modulating executive function and self-awareness (e.g., frontal pole) 7914, 18, 19222021 . Furthermore, robust correlations between anisotropy and symptom severity strongly suggest that neuroanatomical changes may mediate clinical manifestations of IC/BPS that have, until now, been treated as purely peripheral phenomena.
The neurological significance of abnormal white matter properties in IC/BPS may implicate changes in axonal integrity (e.g., number/density of membranes), degree of myelination, fiber organization, and/or axonal branching. Reduced anisotropy is a common (and thus nonspecific) correlate of neurodegenerative disease progression, including loss of cognitive and motor function 23 . Regions with reduced anisotropy that correlated with IC/BPS symptom severity often exhibited increased radial diffusivity, which is suggestive of reduced axonal membrane density, axonal branching, and/or fiber crossing. Interestingly, increased anisotropy is a more unusual finding in clinical populations. Elevated anisotropy and axial diffusivity in frontal and sensorimotor regions may be partially explained by the hypothesis that elevated corticospinal anisotropy is the result of new motor learning, as this process requires the formation of newly myelinated axons needed to enhance anisotropy 24 . As a result, distinct white matter properties are closely linked with symptom severity and potentially new motor learning of postural changes or pelvic floor muscle control related to pain.
It remains unclear whether these white matter properties are causes or consequences of IC/ BPS. White matter architecture may reflect a predisposition to develop disease, given evidence that regional anisotropy predicts future transition to Alzheimer's disease and chronic back pain 11, 25 and may even render a healthy individual vulnerable to develop posttraumatic stress disorder after a traumatic stressor 26 . Alternately, white matter properties distinguished in neurological and psychiatric populations suggest that anisotropy is a consequence of disease progression. For instance, symptom-correlated reductions in regional anisotropy with concurrent increased radial diffusivity are observed with epilepsy 27 , traumatic brain injury 28 , amyotrophic lateral sclerosis 23 , Alzheimer's disease 29 , and schizophrenia 30 . Although neurodegenerative changes are more subtle in chronic pain than in other neurological diseases, these populations consistently show correlations between symptom severity and pathological reductions in anisotropy. In particular, the association between pain with bladder filling and increased brain functional connectivity in women with IC/BPS may reflect altered brain function mediated by anisotropy changes 16 . We speculate that this combination of white matter abnormalities may reflect both the predisposition to develop IC/BPS pain-particularly in regions of decreased anisotropy 11 -as well as consequences of IC/BPS disease progression-in regions of increased anisotropy. Although future longitudinal studies are required to test this hypothesis, the present study has taken the first step in this direction by establishing evidence of neuropathological involvement in IC/BPS.
Potential Clinical Implications
The identification of measurable neuropathological changes underlying IC/BPS advances the ongoing efforts to stratify urological pain patients into mechanistically-distinct subgroups. Such clinical phenotyping requires extremely large sample sizes only attainable through research collaborations like MAPP; yet even data from a limited cross-sectional patient sample reveals that patient-reported symptoms used in IC/BPS diagnosis can tap into biologically-relevant processes that shape axonal microstructure. The second phase of MAPP will use longitudinal neuroimaging to help clarify whether these abnormalities reflect predispositions or consequences of IC/BPS in order to facilitate early detection of vulnerable patient populations requiring early interventions. Conversely, if altered anisotropy is a consequence of IC/BPS, novel therapies that target pain-related neuroplasticity can be added to the treatment arsenal.
CONCLUSION
Novel findings of regional increases and decreases in white matter anisotropy in with women IC/BPS, compared to controls without this syndrome, are associated with pain severity, urological symptoms, and quality of life. These regional changes are found in axonal tracts that traffic information between lobes and hemispheres and may potentially alter the function of communication pathways that transmit sensory, cognitive, and emotional information. IC/BPS white matter abnormalities are therefore candidate markers for neuropathological features of IC/BPS.
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